Cases
Cases
Updated Oct 21, 1:20 PM ET
Petition filed
Plan confirmed
Acorda remains in post-confirmation liquidation, with claims reconciliation ongoing in the July 21, 2026 trustee report Dkt. 675. The trustee's claims-objection deadline is December 31, 2026 under the July 7 extension order Dkt. 673, and a status-conference notice Dkt. 670 schedules the next conference for January 7, 2027.
Search available documents for this case. Full docket access requires Pro.
Open case researchAcorda Therapeutics Sells Assets to Merz for $185 Million, Liquidating Plan Confirmed ·
Case facts and filing dates come from court records.
Updated Oct 21, 1:20 PM ET
Petition filed
Plan confirmed
Acorda remains in post-confirmation liquidation, with claims reconciliation ongoing in the July 21, 2026 trustee report Dkt. 675. The trustee's claims-objection deadline is December 31, 2026 under the July 7 extension order Dkt. 673, and a status-conference notice Dkt. 670 schedules the next conference for January 7, 2027.
Search available documents for this case. Full docket access requires Pro.
Open case researchAcorda Therapeutics Sells Assets to Merz for $185 Million, Liquidating Plan Confirmed ·
Case facts and filing dates come from court records.